Unable to load price data. Sorry.

¯\_(ツ)_/¯

BELLUS Health (NASDAQOTH:BLUS)

CAPS Rating: No stars

A biopharmaceutical company focused on the development and commercialization of innovative therapeutics to address critical unmet medical needs.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

How do you think NASDAQOTH:BLUS will perform against the market?

Add Stock to CAPS Watchlist

All Players

36 Outperform
65 Underperform
 

All-Star Players

3 Outperform
17 Underperform
 

Wall Street

0 Outperform
4 Underperform
 

Top NASDAQOTH:BLUS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

marketfinances (< 20)
Submitted September 15, 2007

Neurochem hires some of the best scientists in the world. I would not be surprised if the Alzheimer drug goes through in Europe(Europe is using more effective tactics to analyse the drug). The potential stock price could reach $60 in a matter of… More

leskimike (< 20)
Submitted May 15, 2007

Historically, the vast majority of researchers have chosen the wrong targets to develop therapies to treat AD. And far too many potential side effects are possible with in the CNS. Neurochem's recent releases hint that the recent trial did not go… More

NASDAQOTH:BLUS VS S&P 500 (SPY)

Fools bullish on NASDAQOTH:BLUS are also bullish on:

Fools bearish on NASDAQOTH:BLUS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about BLUS.

Recs

2
Member Avatar marketfinances (< 20) Submitted: 9/15/2007 1:08:16 AM : Outperform Start Price: $2.86 NASDAQ OTHER:BLUS Score: -188.80

Neurochem hires some of the best scientists in the world. I would not be surprised if the Alzheimer drug goes through in Europe(Europe is using more effective tactics to analyse the drug). The potential stock price could reach $60 in a matter of weeks.

I believe Neurochem's scientists can easily perfect the alheimer drug, which they obviously can.

Recs

0
Member Avatar tharlow (89.78) Submitted: 8/13/2007 2:38:05 PM : Underperform Start Price: $7.36 NASDAQ OTHER:BLUS Score: +210.92

Yay. Another Atherogenics in the making.

Recs

1
Member Avatar Panism (26.33) Submitted: 8/3/2007 10:19:35 PM : Outperform Start Price: $7.01 NASDAQ OTHER:BLUS Score: -213.70

The drug should get approval from FDA

Leaderboard

Find the members with the highest scoring picks in BLUS.

Score Leader

madnessmmrs

madnessmmrs (96.30) Score: +261.59

The Score Leader is the player with the highest score across all their picks in BLUS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
lilaraven 33.83 3/6/2007 Underperform 3Y $14.80 -93.92% +137.35% +231.27 0 Comment
TTGMR2004 62.07 12/8/2006 Underperform 1Y $25.27 -96.44% +133.45% +229.89 0 Comment
nicerobot < 20 1/10/2007 Underperform 3W $18.12 -95.03% +134.33% +229.36 0 Comment
donyao1 99.82 1/9/2007 Underperform NS $18.64 -95.17% +133.97% +229.14 0 Comment
aas3 97.56 1/4/2007 Underperform 5Y $18.41 -95.11% +133.17% +228.28 0 Comment
AugustGray < 20 12/20/2006 Underperform NS $23.51 -96.17% +131.58% +227.75 0 Comment
wcw2 98.58 1/29/2007 Underperform NS $16.92 -94.68% +131.66% +226.34 0 Comment
3acrerock 69.46 1/3/2007 Underperform 1Y $20.03 -95.51% +130.21% +225.72 0 Comment
Lifeguru 59.62 4/13/2007 Underperform 5Y $13.39 -93.28% +126.19% +219.47 0 Comment
tzada 36.29 8/14/2007 Underperform 3Y $7.29 -87.65% +124.58% +212.23 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BLUS.